Vuity - (1.25% ; Ophthalmic Solution)

Generic Name	Pilocarpine Hydrochloride	Innovator	Abbvie
Dosage	1.25% ; Ophthalmic Solution	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	More Than 5	Tentative Approvals	None
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	VUITY is a cholinergic muscarinic receptor agonist indicated for the treatment of presbyopia in adults
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
******	*** \ *********	-**-	*** *********	********	******** ** *** **, ****

Chronology Of Events